Webster's Research Licensed by Audax Medical, Inc.
ChE Chair & Professor Thomas Webster developed a novel self-assembling nanomolecule that is being exclusively licensed by Audax Medical, Inc. for use in tissue regeneration.
ChE Chair & Professor Thomas Webster developed a novel self-assembling nanomolecule that is being exclusively licensed by Audax Medical, Inc. for use in tissue regeneration.